Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the debt to assets ratio high or low?
The debt to assets ratio of 0.20% is 50% below its 5-year average of 0.40%, near the low end of its 5-year range (0.20%–32.92%).
As of the fiscal period ended Tuesday, June 30, 2026. 44.70% below its 12-month average of 0.36%.
Reported quarterly debt to assets ratio; no daily interpolation. Q2 FY2026 (2026-06-30): 0.20%.
DEBT TO ASSETS RATIO
0.20%
DEBT TO ASSETS RATIO AVG TTM
0.36%
DEBT TO ASSETS RATIO AVG 3Y
0.32%
DEBT TO ASSETS RATIO AVG 5Y
0.40%
DEBT TO ASSETS RATIO AVG 10Y
0.26%
DEBT TO ASSETS RATIO AVG 15Y
0.15%
DEBT TO ASSETS RATIO AVG 20Y
0.12%
CURRENT VS TTM AVG
-44.70%
CURRENT VS 3Y AVG
-38.48%
CURRENT VS 5Y AVG
-50.18%
CURRENT VS 10Y AVG
-24.70%
CURRENT VS 15Y AVG
+28.40%
CURRENT VS 20Y AVG
+63.41%
SECTOR MEDIAN · HEALTHCARE
0.09%
median of 873 covered companies
CURRENT VS SECTOR MEDIAN
+120.33%
vs the sector median at left
Oramed Pharmaceuticals Inc.
Market Cap
$179.26M
Debt to Assets Ratio
0.20%
TTM Avg
0.36%
3Y Avg
0.32%
5Y Avg
0.40%
Market Cap
$179.75M
Debt to Assets Ratio
0.05%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$180.47M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$182.60M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$174.27M
Debt to Assets Ratio
0.00%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$173.76M
Debt to Assets Ratio
0.10%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$172.42M
Debt to Assets Ratio
0.16%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$171.13M
Debt to Assets Ratio
0.22%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
Market Cap
$169.53M
Debt to Assets Ratio
0.26%
TTM Avg
N/A
3Y Avg
N/A
5Y Avg
N/A
| NAME | MARKET CAP | DEBT TO ASSETS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Oramed Pharmaceuticals Inc. (ORMP) | $179.26M | 0.20% | 0.36% | 0.32% | 0.40% |
| Compass Therapeutics, Inc. (CMPX)vs › | $179.75M | 0.05% | N/A | N/A | N/A |
| Canton Strategic Holdings Inc (CNTN)vs › | $180.47M | 0.00% | N/A | N/A | N/A |
| AN2 Therapeutics, Inc. (ANTX)vs › | $182.60M | 0.00% | N/A | N/A | N/A |
| Yarrow Bioscience Inc (YARW)vs › | $174.27M | 0.00% | N/A | N/A | N/A |
| ProQR Therapeutics N.V. (PRQR)vs › | $173.76M | 0.10% | N/A | N/A | N/A |
| Organogenesis Holdings Inc. (ORGO)vs › | $172.42M | 0.16% | N/A | N/A | N/A |
| Precision BioSciences, Inc. (DTIL)vs › | $171.13M | 0.22% | N/A | N/A | N/A |
| Journey Medical Corporation (DERM)vs › | $169.53M | 0.26% | N/A | N/A | N/A |
| Eledon Pharmaceuticals, Inc. (ELDN)vs › | $189.11M | 0.00% | N/A | N/A | N/A |
Debt/Assets
0.2%
Debt/Equity
0.00
Current Ratio
4.98
Interest Coverage
N/A
Formula: Debt/Assets = Total Debt / Total Assets × 100
Debt/Assets vs Debt/Equity:
Industry context matters: Capital-intensive industries (utilities, real estate) typically have higher Debt/Assets ratios than tech companies.
Debt/Assets ratio shows what percentage of a company's assets are financed by debt. Compare the current value with the historical chart and peer group to understand leverage over time.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | DEBT TO ASSETS RATIO |
|---|---|
| 2026-06-30 | 0.20% |
| 2026-03-31 | 0.28% |
| 2025-12-31 | 0.36% |
| 2025-09-30 | 0.39% |
| 2025-06-30 | 0.56% |
| 2025-03-31 | 0.20% |
| 2024-12-31 | 0.24% |
| 2024-09-30 | 0.26% |
| 2024-06-30 | 0.26% |
| 2024-03-31 | 15.99% |
| 2023-12-31 | 23.41% |
| 2023-09-30 | 32.92% |
| 2023-06-30 | 0.46% |
| 2023-03-31 | 0.50% |
| 2022-12-31 | 0.55% |
| 2022-09-30 | 0.55% |
| 2022-06-30 | 0.60% |
| 2022-03-31 | 0.64% |
| 2021-11-30 | 0.28% |
| 2021-08-31 | 0.42% |
| 2021-05-31 | 0.70% |
| 2021-02-28 | 0.99% |
| 2020-11-30 | 1.56% |
| 2020-08-31 | 0.17% |
| 2020-05-31 | 0.19% |
| 2020-02-29 | 0.33% |
| 2019-11-30 | 0.34% |
| 2019-08-31 | 0.00% |
| 2019-05-31 | 0.00% |
| 2019-02-28 | 0.00% |
| 2018-11-30 | 0.00% |
| 2018-08-31 | 0.00% |
| 2018-05-31 | 0.00% |
| 2018-02-28 | 0.00% |
| 2017-11-30 | 0.00% |
| 2017-08-31 | 0.00% |
| 2017-05-31 | 0.00% |
| 2017-02-28 | 0.00% |
| 2016-11-30 | 0.00% |
| 2016-08-31 | 0.00% |
| 2016-05-31 | 0.00% |
| 2016-02-29 | 0.00% |
| 2015-11-30 | 0.00% |
| 2015-08-31 | 0.00% |
| 2015-05-31 | 0.00% |
| 2015-02-28 | 0.00% |
| 2014-11-30 | 0.00% |
| 2014-08-31 | 0.00% |
| 2014-05-31 | 0.00% |
| 2014-02-28 | 0.00% |
| 2013-11-30 | 0.00% |
| 2013-08-31 | 0.00% |
| 2013-05-31 | 0.00% |
| 2013-02-28 | 0.00% |
| 2012-11-30 | 0.00% |
| 2012-08-31 | 0.00% |
| 2012-05-31 | 0.00% |
| 2012-02-29 | 0.00% |
| 2011-11-30 | 0.00% |
| 2011-08-31 | 0.00% |
| 2011-05-31 | 0.00% |
| 2011-02-28 | 0.00% |
| 2010-11-30 | 0.00% |
| 2010-08-31 | 0.00% |
| 2010-05-31 | 0.00% |
| 2010-02-28 | 0.00% |
| 2009-11-30 | 0.00% |
| 2009-08-31 | 0.00% |
| 2009-05-31 | 0.00% |
| 2009-02-28 | 0.00% |
| 2008-11-30 | 0.00% |
| 2008-08-31 | 0.00% |
| 2008-05-31 | 0.00% |
| 2008-02-29 | 20.85% |
| 2007-11-30 | 17.56% |
| 2007-08-31 | 14.20% |
| 2007-05-31 | 28.55% |
| 2007-02-28 | 93.69% |
| 2006-11-30 | 0.00% |
| 2006-08-31 | 0.00% |
| 2006-05-31 | 0.00% |
| 2005-08-31 | 0.00% |
| 2004-02-29 | 0.00% |
| 2003-11-30 | 0.00% |
| 2003-08-31 | 0.00% |
| 2003-05-31 | 0.00% |
